Clinical Trials on Triple Negative Breast Neoplasms in Russian Federation
Total 257 results
-
Russian Academy of Medical SciencesCompletedEarly Triple Negative Breast CancerRussian Federation
-
Russian Academy of Medical SciencesCompletedInduction Preoperative Chemotherapy for Patients With Locally Advanced Triple Negative Breast CancerTriple Negative Breast CancerRussian Federation
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States, Spain, China, France, Australia, Georgia, Poland, Bulgaria, Moldova, Republic of, Russian Federation, Ukraine
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
Novartis PharmaceuticalsCompletedBreast CancerSpain, United Kingdom, Taiwan, Australia, Russian Federation, Germany, Korea, Republic of, Ireland, United States, Italy, Brazil, Czech Republic
-
OBI Pharma, IncRecruitingTriple Negative Breast CancerChina, Taiwan, United States, Korea, Republic of, Australia, Brazil, Hong Kong, Mexico, Russian Federation, South Africa, Ukraine, Peru, Poland
-
AbbVieNSABP Foundation Inc; German Breast Group; US Oncology Research; Grupo Espanol...CompletedTriple Negative Breast CancerUnited States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
Hoffmann-La RocheCompletedBreast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Brazil, France, Slovenia, Spain, Taiwan, Japan, Italy, Argentina, India, Germany, Hungary, Russian Federation, Singapore, Ukraine, Costa Rica, Czechia, G... and more
-
Hoffmann-La RocheCompletedTriple Negative Breast CancerUnited States, Korea, Republic of, Belgium, Canada, Germany, United Kingdom, Argentina, Australia, Brazil, Finland, France, Greece, Hungary, Poland, Slovenia, Spain, Taiwan, Turkey, Japan, Singapore, Colombia, Bosnia and Herzegovina, Guatema... and more
-
Hoffmann-La RocheBreast International Group; Frontier Science & Technology Research Foundation... and other collaboratorsCompletedTriple Negative Breast CancerRussian Federation, United States, Israel, Italy, Spain, France, Korea, Republic of, United Kingdom, Denmark, Taiwan, Hungary, Argentina, Australia, Austria, Belgium, Brazil, China, Germany, Hong Kong, Japan, Mexico, Romania, Switze... and more
-
Eli Lilly and CompanyCompletedBreast Cancer | Neoplasm MetastasisRussian Federation
-
GlaxoSmithKlineActive, not recruitingNeoplasms, BreastUnited States, Argentina, France, Netherlands, Finland, Spain, Israel, Poland, Romania, Mexico, Canada, Belgium, Germany, Hungary, Portugal, United Kingdom, Ireland, Australia, Italy, Brazil, Japan, Austria, Russian Federation, South... and more
-
EMD Serono Research & Development Institute, Inc.Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...TerminatedTriple Negative Breast NeoplasmsUnited States, France, Belgium, Spain, Russian Federation, Italy
-
Novartis PharmaceuticalsActive, not recruitingTriple Negative Breast NeoplasmsFrance, Italy, Croatia, Taiwan, Australia, Argentina, Korea, Republic of, China, Israel, Russian Federation, Slovakia, Slovenia, United Kingdom, Germany, Mexico, Switzerland, Spain, Brazil, Hungary, Malaysia, South Africa, Austria, ... and more
-
ARNA Genomics US Inc.BIOMARKER-RURecruitingBreast Neoplasm FemaleRussian Federation
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
Merck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast NeoplasmsBrazil, Canada, United States, United Kingdom, Taiwan, Australia, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Poland, Portugal, Russian Federation, Singapore, Spain, Sweden, Turkey
-
AstraZenecaActive, not recruitingTriple Negative Breast NeoplasmsUnited States, Spain, Sweden, Taiwan, Thailand, Vietnam, Turkey, Russian Federation, France, Korea, Republic of, United Kingdom, Brazil, Czechia, Hungary, India, Japan, Mexico, Peru, Philippines, Poland, China, Malaysia, Canada, Portugal and more
-
Blokhin's Russian Cancer Research CenterRussian Society of Clinical OncologyCompletedMetastatic Disease | HR+/HER2- Breast Cancer | Аdvanced DiseaseRussian Federation
-
Hoffmann-La RocheActive, not recruitingTriple Negative Breast NeoplasmsKorea, Republic of, Italy, China, Finland, France, Hungary, Spain, United Kingdom, Argentina, United States, Bosnia and Herzegovina, Brazil, Chile, Germany, Poland, Russian Federation, Peru, Morocco, Mexico, Portugal, Serbia, Turkey, South Africa and more
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedBreast Cancer FemaleRussian Federation
-
Tomsk National Research Medical Center of the Russian...RecruitingPrimary Breast CancerRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedBreast Cancer FemaleRussian Federation
-
Tomsk National Research Medical Center of the Russian...Enrolling by invitationBreast Cancer FemaleRussian Federation
-
Tomsk National Research Medical Center of the Russian...CompletedBreast Cancer FemaleRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala University; Institute of Bioorganic Chemistry, Russian Academy of SciencesCompletedPrimary Breast CancerRussian Federation
-
Center of Personalized Medicine, PirogovaI.M. Sechenov First Moscow State Medical University; Center for New Medical...UnknownBreast Cancer-specific SurvivalRussian Federation
-
Blokhin's Russian Cancer Research CenterRecruitingBreast Cancer Stage IVRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedFemale | HER2-positive Breast CancerRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala University; KTH Royal Institute of TechnologyCompleted
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedBreast Cancer | FemaleRussian Federation
-
Blokhin's Russian Cancer Research CenterRecruitingBreast Cancer | Neoadjuvant Endocrine TherapyRussian Federation
-
Alpha Tau Medical LTD.TerminatedMetastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Distant Metastases.PathologyRussian Federation
-
Tatarstan Cancer CenterUnknownHereditary Breast CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...UnknownBreast CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...UnknownBreast CancerRussian Federation
-
BiocadCompletedBreast CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...RecruitingOligometastatic Disease | HER2-positive Metastatic Breast CancerRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedProstate Cancer | Breast Cancer FemaleRussian Federation
-
KARANAHANRecruitingStage IV Breast CancerRussian Federation
-
Eli Lilly and CompanyCompleted
-
Antisoma ResearchTerminatedBreast CarcinomaRussian Federation
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityRecruitingBreast Cancer | Prostate CancerRussian Federation
-
N.N. Petrov National Medical Research Center of...RecruitingRefusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNBRussian Federation
-
Saint Petersburg State University, RussiaNot yet recruitingBreast Neoplasms | Sentinel Lymph NodeRussian Federation
-
Moscow Clinical Scientific CenterNegovsky Reanimatology Research InstituteRecruiting
-
BiocadRecruitingBreast CancerRussian Federation
-
Moscow Clinical Scientific CenterRecruitingBreast Cancer | Solid Tumor | Gastrointestinal Cancer | Gynecological Malignancies | High-Risk Cancer | MyelosuppressionRussian Federation